These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32286882)

  • 1. HDL-apoA-I kinetics in response to 16 wk of exercise training in men with nonalcoholic fatty liver disease.
    Whyte MB; Shojaee-Moradie F; Sharaf SE; Cuthbertson DJ; Kemp GJ; Barrett M; Jackson NC; Herring RA; Wright J; Thomas EL; Bell J; Umpleby AM
    Am J Physiol Endocrinol Metab; 2020 Jun; 318(6):E839-E847. PubMed ID: 32286882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exercise Training Reduces Liver Fat and Increases Rates of VLDL Clearance But Not VLDL Production in NAFLD.
    Shojaee-Moradie F; Cuthbertson DJ; Barrett M; Jackson NC; Herring R; Thomas EL; Bell J; Kemp GJ; Wright J; Umpleby AM
    J Clin Endocrinol Metab; 2016 Nov; 101(11):4219-4228. PubMed ID: 27583475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interrelationships between the kinetics of VLDL subspecies and HDL catabolism in abdominal obesity: a multicenter tracer kinetic study.
    Vergès B; Adiels M; Boren J; Barrett PH; Watts GF; Chan D; Duvillard L; Söderlund S; Matikainen N; Kahri J; Robin I; Taskinen MR
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4281-90. PubMed ID: 25077901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Very low density lipoprotein metabolism and plasma adiponectin as predictors of high-density lipoprotein apolipoprotein A-I kinetics in obese and nonobese men.
    Chan DC; Barrett PH; Ooi EM; Ji J; Chan DT; Watts GF
    J Clin Endocrinol Metab; 2009 Mar; 94(3):989-97. PubMed ID: 19116237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
    Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of liver fat on the differential partitioning of hepatic triacylglycerol into VLDL subclasses on high and low sugar diets.
    Umpleby AM; Shojaee-Moradie F; Fielding B; Li X; Marino A; Alsini N; Isherwood C; Jackson N; Ahmad A; Stolinski M; Lovegrove JA; Johnsen S; Jeewaka R Mendis AS; Wright J; Wilinska ME; Hovorka R; Bell JD; Thomas EL; Frost GS; Griffin BA
    Clin Sci (Lond); 2017 Nov; 131(21):2561-2573. PubMed ID: 28923880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity.
    Riches FM; Watts GF; Naoumova RP; Kelly JM; Croft KD; Thompson GR
    Int J Obes Relat Metab Disord; 1998 May; 22(5):414-23. PubMed ID: 9622338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma apolipoprotein C-III transport in centrally obese men: associations with very low-density lipoprotein apolipoprotein B and high-density lipoprotein apolipoprotein A-I metabolism.
    Chan DC; Nguyen MN; Watts GF; Barrett PH
    J Clin Endocrinol Metab; 2008 Feb; 93(2):557-64. PubMed ID: 18000086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omega-3 fatty acid ethyl ester supplementation decreases very-low-density lipoprotein triacylglycerol secretion in obese men.
    Wong AT; Chan DC; Ooi EM; Ng TW; Watts GF; Barrett PH
    Clin Sci (Lond); 2013 Mar; 125(1):45-51. PubMed ID: 23356247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein B-100 and apoA-II kinetics as determinants of cellular cholesterol efflux.
    Chan DC; Hoang A; Barrett PH; Wong AT; Nestel PJ; Sviridov D; Watts GF
    J Clin Endocrinol Metab; 2012 Sep; 97(9):E1658-66. PubMed ID: 22745238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein A-II and adiponectin as determinants of very low-density lipoprotein apolipoprotein B-100 metabolism in nonobese men.
    Chan DC; Watts GF; Ooi EM; Chan DT; Wong AT; Barrett PH
    Metabolism; 2011 Oct; 60(10):1482-7. PubMed ID: 21550083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of an isoenergetic traditional Mediterranean diet on apolipoprotein A-I kinetic in men with metabolic syndrome.
    Richard C; Couture P; Desroches S; Lichtenstein AH; Lamarche B
    Nutr J; 2013 Jun; 12(1):76. PubMed ID: 24499022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-density lipoprotein apolipoprotein A-I kinetics: comparison of radioactive and stable isotope studies.
    Ooi EM; Watts GF; Farvid MS; Chan DC; Allen MC; Zilko SR; Barrett PH
    Eur J Clin Invest; 2006 Sep; 36(9):626-32. PubMed ID: 16919045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity.
    Ooi EM; Watts GF; Sprecher DL; Chan DC; Barrett PH
    J Clin Endocrinol Metab; 2011 Oct; 96(10):E1568-76. PubMed ID: 21816786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution.
    Brinton EA; Eisenberg S; Breslow JL
    Arterioscler Thromb; 1994 May; 14(5):707-20. PubMed ID: 8172849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ApoA-II HDL Catabolism and Its Relationships With the Kinetics of ApoA-I HDL and of VLDL1, in Abdominal Obesity.
    Vergès B; Adiels M; Boren J; Barrett PH; Watts GF; Chan D; Duvillard L; Söderlund S; Matikainen N; Kahri J; Lundbom N; Lundbom J; Hakkarainen A; Aho S; Simoneau-Robin I; Taskinen MR
    J Clin Endocrinol Metab; 2016 Apr; 101(4):1398-406. PubMed ID: 26835543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein A-I, B-100, and B-48 metabolism in subjects with chronic kidney disease, obesity, and the metabolic syndrome.
    Batista MC; Welty FK; Diffenderfer MR; Sarnak MJ; Schaefer EJ; Lamon-Fava S; Asztalos BF; Dolnikowski GG; Brousseau ME; Marsh JB
    Metabolism; 2004 Oct; 53(10):1255-61. PubMed ID: 15375779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between skeletal muscle fat content and very-low-density lipoprotein-apolipoprotein B-100 transport in obesity: effect of weight loss.
    Chan DC; Gan SK; Wong AT; Barrett PH; Watts GF
    Diabetes Obes Metab; 2014 Oct; 16(10):994-1000. PubMed ID: 24821431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adiponectin is an important determinant of apoA-I catabolism.
    Vergès B; Petit JM; Duvillard L; Dautin G; Florentin E; Galland F; Gambert P
    Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1364-9. PubMed ID: 16574896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel method for measuring intestinal and hepatic triacylglycerol kinetics.
    Sun F; Stolinski M; Shojaee-Moradie F; Lou S; Ma Y; Hovorka R; Umpleby AM
    Am J Physiol Endocrinol Metab; 2013 Oct; 305(8):E1041-7. PubMed ID: 23592484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.